Form D · Biotechnology
Aufbau Holdings Ltd
Dublin 2, L2 · CIK 0001788081
Offering snapshot reported Apr 25, 2025 · SEC filing
- Reported sold
- $6.1M Offering amount: $20M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2025 | Initial | $6,099,912 | No comparison | 8 | SEC filing |
| Nov 15, 2023 | Initial | $1,087,980 | No comparison | 29 | SEC filing |
| Apr 27, 2021 | Initial | $5,450,000 | No comparison | Not reported | SEC filing |
| Sep 13, 2019 | Initial | $1,135,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-544487
Source: Form D, filed Apr 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert C. Hazlett | Executive |
| John Irwin | Director |
| Wayne Merkelson | Executive |
| James Mitchell | Director, Executive |
| John T.G. Pena | Director, Executive |
| Chairatch Phrompechrut | Executive |
| H. Lawrence Remmel | Director |
| Bruce R. Thaw | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Palmerston House Fenian Street
Dublin 2, L2, D02 WD37
Dublin 2, L2, D02 WD37